| Literature DB >> 27619997 |
Dipti Vijayan1,2, Norhanani Mohd Redzwan1, Danielle T Avery1, Rushika C Wirasinha1, Robert Brink1,2, Giles Walters3,4,5, Stephen Adelstein6, Masao Kobayashi7, Paul Gray8, Michael Elliott9,10, Melanie Wong11, Cecile King1,2, Carola G Vinuesa3, Nico Ghilardi12, Cindy S Ma1,2, Stuart G Tangye1,2, Marcel Batten13,2.
Abstract
Germinal centers (GC) give rise to high-affinity and long-lived Abs and are critical in immunity and autoimmunity. IL-27 supports GCs by promoting survival and function of T follicular helper cells. We demonstrate that IL-27 also directly enhances GC B cell function. Exposure of naive human B cells to rIL-27 during in vitro activation enhanced their differentiation into CD20+CD38+CD27lowCD95+CD10+ cells, consistent with the surface marker phenotype of GC B cells. This effect was inhibited by loss-of-function mutations in STAT1 but not STAT3 To extend these findings, we studied the in vivo effects of IL-27 signals to B cells in the GC-driven Roquinsan/san lupus mouse model. Il27ra-/-Roquinsan/san mice exhibited significantly reduced GCs, IgG2a(c)+ autoantibodies, and nephritis. Mixed bone marrow chimeras confirmed that IL-27 acts through B cell- and CD4+ T cell-intrinsic mechanisms to support GCs and alter the production of pathogenic Ig isotypes. To our knowledge, our data provide the first evidence that IL-27 signals directly to B cells promote GCs and support the role of IL-27 in lupus.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27619997 DOI: 10.4049/jimmunol.1600652
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422